Vitamin D and Longevity: Correcting a Deficiency, Not Chasing a Number
Low vitamin D is genuinely common and associated with worse health — yet large trials show that supplementing people who are already replete does little. The nuance is the whole point.
Vitamin D occupies an unusual place in longevity: deficiency is real, common and worth correcting, yet it has also been over-sold as a cure-all. The honest picture, from large trials, is more specific — fixing a true deficiency matters, while pushing an already-adequate level higher does surprisingly little. Knowing the difference is what makes the number useful.
What it is and how it's measured
Vitamin D is a hormone the skin makes from sunlight, and that we also get from a few foods (oily fish, egg yolk, fortified products) and supplements. It is central to calcium balance and bone health, with receptors found in many tissues throughout the body (Bouillon et al., 2019). The blood level is measured as 25-hydroxyvitamin D (25-OH-D).
Expert panels generally treat levels below about 30 nmol/L (12 ng/mL) as deficient and around 50 nmol/L (20 ng/mL) as sufficient for most people's bone health (Ross et al., 2011). Deficiency is widespread at high latitudes and in winter, when sunlight is too weak for the skin to make enough.
Why deficiency matters
Clear deficiency causes bone disease — rickets in children, osteomalacia and increased fracture risk in adults — and observational studies consistently link low 25-OH-D to higher rates of many conditions and to higher mortality (Holick, 2007; Chowdhury et al., 2014).
The catch with those observational links is that low vitamin D is often a marker of poor health rather than its cause: illness, inactivity and little time outdoors all lower it. That is exactly why randomised trials are needed to separate cause from correlation.
What the evidence supports — and doesn't
When large randomised trials tested vitamin D supplements in generally replete adults, the results were sobering: in the VITAL trial, supplementation did not reduce cardiovascular disease or cancer overall (Manson et al., 2019), and it did not lower fracture risk in adults who were not deficient. In other words, more is not better once you have enough.
The consistent signal is narrower and real: correcting a genuine deficiency benefits bone health and is sensible, whereas high-dose supplementation on top of sufficiency has not been shown to extend healthspan and can, at very high doses, cause harm.
The practical takeaway
If you live far from the equator, spend little time in the sun, have darker skin, are older, or carry excess weight, you are more likely to be low — a simple 25-OH-D blood test settles it. If you are deficient, a modest daily dose to reach sufficiency is well justified; if you are already replete, there is little reason to chase a higher number.
Treat vitamin D as a deficiency to correct, not a lever to maximise. Retest occasionally, avoid very high unmonitored doses, and set your target with a qualified professional in the context of your overall health.
References
Holick M.F. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266–281.
Bouillon R. et al. (2019). Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocrine Reviews, 40(4), 1109–1151.
Chowdhury R. et al. (2014). Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ, 348, g1903.
Manson J.E. et al. (2019). Vitamin D supplements and prevention of cancer and cardiovascular disease. New England Journal of Medicine, 380(1), 33–44.
Ross A.C. et al. (2011). The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine. Journal of Clinical Endocrinology & Metabolism, 96(1), 53–58.
Articles in this section are educational and are not medical advice, a diagnosis, or a prescription. Consult a qualified professional before acting on anything you read here.
Read next
ExplainerMedicine and treatmentFlat feet in children and adolescents: when to observe, when to treat, and what the evidence shows
In most children a flat foot is a shape, not a disease: the arch matures on its own in the first decade. What decides is whether the foot is flexible and whether it hurts. What the insole trials showed, how a rigid foot differs from a flexible one, when surgery is discussed at all, and what to ask the orthopaedic surgeon.
16 min read
ExplainerBiomarkersWhat limits VO2max — lungs, heart or muscles — and how accurate the estimates are
VO2max is often described as a measure of the lungs. In healthy people the ceiling is set mostly by how much oxygen the heart and blood can deliver; the lungs become the limit only in particular situations. What changes with age, and how accurate lab tests, formulas and watches are.
12 min read
ExplainerSleepMouth breathing during sleep in children: why it is not a habit, and what the treatment evidence shows
An open mouth at night usually means breathing through the nose or throat is harder, but the sign alone does not make a diagnosis. How sleep-disordered breathing in children and teenagers is confirmed, what trials of adenotonsillectomy, medicines, nasal treatment, orthodontics and exercises found, and where evidence is still missing.
15 min read